Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Pituitary Neoplasms

• Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
• Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection
• Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery
• Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery
• Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor
• Hydrocortisone Use During Peri-operation for Pituitary Adenomas
• Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas
• Corticotrophin-releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing s Disease
• The TMS Treatment for Postoperative Headache in GH Tumor
• Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
• TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas
• The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas
• Detection of PitNET Tissue During TSS Using Bevacizumab-800CW
• PRolaCT - Three Prolactinoma RCTs
• Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
• Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
• Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
• Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
• Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
• Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT
• A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas
• Cabergoline in Nonfunctioning Pituitary Adenomas
• Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
• Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
• Intraoperative Imaging of Pituitary Adenomas by OTL
• Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
• Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests
• Intraoperative Imaging of Pituitary Adenomas by OTL
• Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
• Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
• Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
• Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas
• Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
• Peri-Operative Steroid Management in Patients
• Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
• Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
• Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
• Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
• Surgical Debulking of Pituitary Adenomas
• Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
• Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas
• Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
• Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone
• Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
• Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
• Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
• Rosiglitazone in Treating Patients With Pituitary Tumors
• Temozolomide in Treating Patients With Invasive Pituitary Tumors
• Effect of 5 Years of GH Replacement on Atherosclerosis
• Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
• Sandostatin LAR Depot vs. Surgery for Treating Acromegaly